PolyNovo Limited (formerly known as Calzada limited), Melbourne, Australia has partnered with Prof Toby Coates and Prof John Greenwood to find out an alternative technology to islet cell transplantation for the treatment of patients with type 1 diabetes (T1D).
The Benefits Of Brisk Walk
A study at the Duke University School of Medicine shows that the brisk walking is more effective compared to jogging in lowering the blood sugar (glucose) levels in people with prediabetes.
The researchers say that a high-intensity exercise can burn more glucose and moderate intensity exercise can burn more fat.
A brisk walk of 11.5 miles per week is better than jogging the same distance for people with prediabetes.
The lead author of the study is Dr. William Kraus, M.D. The study was published in the Journal Diabetologia.
About Beta Cell 'Hubs'
A study by Dr. David Hodson, the University of Birmingham says between 65 and 80 percent of the islet cells in the pancreas are beta cells.
The study has found that just one to ten percent of the beta cells are controlling the secretion of insulin in response to sugar (glucose) present in the blood. The failure of these cells can lead to diabetes.
The study was conducted on mice, rat and human models. The study was published in Cell Metabolism.
The Benefits Of Breastfeeding
A study at Helmholtz Zentrum Muenchen, Germany shows that those women who had gestational diabetes (GD) during the pregnancy can protect themselves against the risk of type 2 diabetes (T2D) by breastfeeding for more than three months.
The three months of breastfeeding can cause long-term metabolic change and protection from type 2 diabetes (T2D) for at least 15 years.
Gender Specific Risk Factors For Diabetes
Gender is not considered a factor in the international guidelines for the management of type 2 diabetes (T2D). A study by Alexandra Kautzky-Willer, Medical University of Vienna, Austria, says that the treatment for diabetes should be gender-specific. The risk factors and their effects on patients of type 2 diabetes (T2D) are different in men and women.
The researchers say that the gender-specific risks should be incorporated in the international guidelines for the management of diabetes mellitus. The following are the differences between men and women patients with diabetes.
The Risk From Teenage Obesity
A study at the Sheba Medical Center, Israel, has found that teenage obesity may cause death.
The study was published in the New England Journal of Medicine on Apr 13, 2016.
Approval Of Synjardy XR Tablets
The Food and Drug Administration (FDA) has approved the synjardy XR tablets. This drug can improve the glycemic control in adult patients with type 2 diabetes (T2D).
Synjardy is a single pill combination drug. Synjardy contains empagliflozin and metformin hydrochloride. Synjardy XR is a prescription drug and the drug can lower A1C levels significantly after 24 weeks of use.
The most common side effects of the drug are nausea, vomit and tiredness.
About Qtern Drug
Qtern added to metformin has shown a significant reduction in HbA1c when compared with other drug combinations. Qtern drug has received approval from the European Commission.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.